Analysis of Coronavirus-Host Cell Interactions
Analysis of Coronavirus-Host Cell Interactions
批准号:
9014501
负责人:
Shinji Makino
金额:
$38.25万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-15 至 2018-02-28
关键词:
5&apos Untranslated RegionsAddressAntiviral AgentsBindingBinding SitesBiological ModelsBiological ProcessCell CommunicationCell ExtractsCellsChinaChiropteraComplexCoronavirusCoronavirus InfectionsCountryDisease OutbreaksFamily PicornaviridaeFoundationsFutureGene ExpressionGenesGenetic TranslationGenomeHela CellsHepatitis C virusHumanIntegration Host FactorsInterferon Type IInterferonsInternal Ribosome Entry SiteKnowledgeLung diseasesMapsMessenger RNAMolecularMurine hepatitis virusNonstructural ProteinOryctolagus cuniculusPathogenesisPathogenicityPeptide Initiation FactorsPlayPolyproteinsProcessProductionProtein BiosynthesisProteinsRNARNA chemical synthesisRegulationResistanceResourcesReticulocytesRibonucleasesRibosomesRoleSARS coronavirusSevere Acute Respiratory SyndromeSystemTestingTranslation InitiationTranslationsTransmissible gastroenteritis virusViralViral GenesViral GenomeViral ProteinsVirulence FactorsViruscricket paralysis viruseIF-4Binhibitor/antagonistmRNA Transcript Degradationmortalitynoveltranslational approachviral RNA
中文摘要
描述(由申请人提供):冠状病毒(CoV)感染后立即开始病毒基因组的翻译,以产生两个大的多蛋白,这些多蛋白被加工成15或16个成熟的非结构蛋白。这些蛋白质大多数参与病毒RNA合成,有些具有其他生物学功能。包括sars冠状病毒(SCoV)、蝙蝠冠状病毒和小鼠肝炎病毒(MHV)在内的β - acovs和包括传染性胃肠炎病毒(TGEV)和人冠状病毒229E在内的α - acovs的nsp1蛋白抑制宿主基因表达。既往研究表明,抑制宿主基因表达的病毒蛋白是主要毒力因子,nsp1蛋白很可能在冠状病毒的发病过程中起关键作用。与这一观点一致的是,MHV nsp1是一个主要的毒力因子,而SCoV nsp1抑制感染细胞中I型干扰素和干扰素刺激基因的产生。不同冠状病毒的Nsp1蛋白具有抑制宿主基因表达的共同生物学功能,但发挥这一功能的策略不同。SCoV nsp1使用一种新的双管齐下的策略来抑制宿主蛋白合成/基因表达。SCoV nsp1结合40S核糖体亚基抑制mRNA翻译,并诱导模板依赖性内溶mRNA裂解。与SCoV nsp1相比,TGEV nsp1采用不同的策略来抑制mRNA翻译,因为它不能结合40S核糖体亚基或促进宿主mRNA降解。本申请旨在以SCoV和TGEV nsp1蛋白为模型系统,描述CoV nsp1诱导的基因表达抑制的新机制。我们将揭示SCoV nsp1诱导模板依赖性mRNA切割的机制。我们还将阐明SCoV和TGEV nsp1诱导翻译抑制的不同机制,并揭示在nsp1诱导的翻译抑制条件下,SCoV感染细胞中允许病毒基因强劲表达的策略。本研究将为了解冠状病毒对宿主基因表达的调控提供基础,扩大我们在分子水平上对冠状病毒致病性的认识,并有可能发现调控真核基因表达的新机制。
英文摘要
DESCRIPTION (provided by applicant): The translation of the viral genome begins immediately after coronavirus (CoV) infection to produce two large polyproteins that are processed into 15 or 16 mature, nonstructural proteins. Most of these proteins are involved in viral RNA synthesis, and some have other biological functions. The nsp1 protein of betaCoVs, which includes SARS-CoV (SCoV), bat CoVs, and mouse hepatitis virus (MHV), and of alphaCoVs, which includes transmissible gastroenteritis virus (TGEV) and human CoV 229E, inhibits host gene expression. As past studies have shown that viral proteins that inhibit host gene expression are major virulence factors, nsp1 proteins of CoVs most probably play a critical role in CoV pathogenesis. Consistent with this notion, MHV nsp1 is a major virulence factor, and SCoV nsp1 inhibits the production of type I interferon and interferon-stimulated genes in infected cells. Nsp1 proteins of different CoVs share a common biological function to inhibit host gene expression but use different strategies to exert this function. SCoV nsp1 uses a novel, two-pronged strategy to inhibit host protein synthesis/gene expression. SCoV nsp1 binds to the 40S ribosomal subunit to inhibit mRNA translation and also induces a template-dependent endonucleolytic mRNA cleavage. In contrast to SCoV nsp1, TGEV nsp1 employs a different strategy to inhibit mRNA translation, as it is unable to bind the 40S ribosomal subunit or promote host mRNA degradation. This application aims to delineate the novel mechanisms of CoV nsp1-induced inhibition of gene expression by using SCoV and TGEV nsp1 proteins as model systems. We will uncover the mechanism of SCoV nsp1-induced template-dependent mRNA cleavage. We will also clarify the different mechanisms of SCoV and TGEV nsp1-induced translation inhibition and reveal the strategy that allows robust viral gene expression in SCoV-infected cells under conditions of nsp1-induced translation inhibition. The proposed studies will provide a foundation for understanding the modulation of host gene expression by CoV, expand our knowledge of CoV pathogenicity at the molecular level, and potentially identify a novel mechanism for the regulation of eukaryotic gene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
-
批准号:10057583
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2020
-
负责人:Shinji Makino
-
依托单位:
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
-
批准号:10188412
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2020
-
负责人:Shinji Makino
-
依托单位:
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
-
批准号:10358595
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2020
-
负责人:Shinji Makino
-
依托单位:
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
-
批准号:10614383
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2020
-
负责人:Shinji Makino
-
依托单位:
Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine
-
批准号:9386475
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2017
-
负责人:Shinji Makino
-
依托单位:
Development of Safer,Live Attenuated Rift Valley Fever Vaccines
-
批准号:9091408
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2015
-
负责人:Shinji Makino
-
依托单位:
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1
-
批准号:9189963
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2015
-
负责人:Shinji Makino
-
依托单位:
Development of a Novel Rift Valley Fever Virus Vaccine
-
批准号:8604678
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2013
-
负责人:Shinji Makino
-
依托单位:
Development of a Novel Rift Valley Fever Virus Vaccine
-
批准号:8509347
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2013
-
负责人:Shinji Makino
-
依托单位:
Analysis of Coronavirus-Host Cell Interactions
-
批准号:8442842
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2012
-
负责人:Shinji Makino
-
依托单位:
Analysis of Coronavirus-Host Cell Interactions
-
批准号:8888201
-
项目类别:
-
资助金额:$3.03万
-
财政年份:2012
-
负责人:Shinji Makino
-
依托单位:
Analysis of Coronavirus-Host Cell Interactions
-
批准号:8617794
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:Shinji Makino
-
依托单位:
Analysis of Coronavirus-Host Cell Interactions
-
批准号:8795658
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2012
-
负责人:Shinji Makino
-
依托单位:
Analysis of Coronavirus-Host Cell Interactions
-
批准号:8272174
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:Shinji Makino
-
依托单位:
Toward Control of Rift Valley Fever Virus Replication
-
批准号:7676542
-
项目类别:
-
资助金额:$15.21万
-
财政年份:2009
-
负责人:Shinji Makino
-
依托单位:
Toward Control of Rift Valley Fever Virus Replication
-
批准号:7649091
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2008
-
负责人:Shinji Makino
-
依托单位:
Analysis of SARS Coronavirus-Host Cell Interactions
-
批准号:7315177
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2007
-
负责人:Shinji Makino
-
依托单位:
Analysis of SARS Coronavirus-Host Cell Interactions
-
批准号:7892427
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2007
-
负责人:Shinji Makino
-
依托单位:
Analysis of SARS Coronavirus-Host Cell Interactions
-
批准号:7477812
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2007
-
负责人:Shinji Makino
-
依托单位:
Analysis of SARS Coronavirus-Host Cell Interactions
-
批准号:7661664
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2007
-
负责人:Shinji Makino
-
依托单位:
海外基金